1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood conditions

Crizanlizumab for preventing sickle cell crises in sickle cell disease

Technology appraisal guidance [TA743] Published: 03 November 2021

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Tools and resources

Tools to help you put the guidance into practice.

Education

  • Managed access agreement PDF 552 KB 03 November 2021  

Resource impact

  • Resource impact statement  

Related news

  • NICE recommends first treatment in two decades for sickle cell disease  

Guidance into practice

  • About the Into practice guide  
  • Practical steps to improving the quality of care and services using NICE guidance